YP

Yagnesh Patel

Active Director Additional Director DIN 10803007
DIN 10803007 First appointment Oct 2024 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Yagnesh Patel

Data last updated:

Yagnesh Patel is an Additional Director at Antecessor India Dna Private Limited (since 2024). The company operates in Biotechnology.

DIN 10803007
Primary Designation Additional Director
Industry Biotechnology
First Appointment 23 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Antecessor India Dna Private Limited U86905KA2024PTC192929
Additional Director23 Oct 20242024Active

Board colleagues of Yagnesh Patel

Directorship timeline

Open interactive timeline →
Antecessor India Dna Private Limited
Premium access

Shareholding and investment profile for Yagnesh Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yagnesh Patel

Yagnesh Patel currently holds 1 directorship: Antecessor India Dna Private Limited (Additional Director, since 23 Oct 2024).

Yagnesh Patel was first appointed on 23 Oct 2024 as Additional Director at Antecessor India Dna Private Limited.

The current boards of Yagnesh Patel's companies include Charan Govindrajulu Kumar (Antecessor India Dna Private Limited), Michael Scott Borish (Antecessor India Dna Private Limited), Thirupathi Narasimhalunaidu Venkatesh (Antecessor India Dna Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available